Key result
Atrial prevention pacing did not decrease device-recorded AT/AF frequency compared to OFF, but reduced symptomatic AT/AF episodes in patients with septal leads.
Why the study?
The combined role of atrial septal lead location and atrial pacing algorithms in preventing atrial tachyarrhythmias is unknown.
Do atrial prevention pacing algorithms reduce AT/AF frequency or burden in patients with bradycardia and paroxysmal AT/AF implanted with a DDDRP pacing system?
RCT (n=298)
Randomized cross-over
Yes
Do atrial prevention pacing algorithms reduce AT/AF frequency or burden in patients with bradycardia and paroxysmal AT/AF implanted with a DDDRP pacing system?
Atrial prevention pacing algorithms do not reduce device-recorded AT/AF burden, though they may reduce premature atrial contractions and symptomatic episodes in patients with septal leads.
Answers are grounded in this paper and cite their sources.
Prevention pacing algorithms do not reduce device-recorded AT/AF burden; confirms lack of efficacy and challenges routine activation in bradycardia patients with paroxysmal AF.
Introduction: The combined role of atrial septal lead location and atrial pacing algorithms in the prevention of atrial tachyarrhythmias (AT/AF), including both atrial fibrillation and flutter, is unknown. We tested the hypothesis that atrial prevention pacing algorithms could decrease AT/AF frequency in patients with atrial septal leads, bradycardia, and paroxysmal AT/AF. Methods and Results: A total of 298 patients (age 70 ± 10 years; 61% male) from 35 centers were implanted with a DDDRP pacing system including three AT/AF prevention pacing algorithms. Lead site was randomized at implant to right atrial septal or nonseptal. Patients were randomized 1 month postimplant to AT/AF prevention ON or OFF for 3 months and then crossed over for 3 months. Patients logged symptomatic AT/AF episodes via a manual activator. Prevention efficacy was evaluated based on intention‐to‐treat in 277 patients (138 septal) with complete follow‐up. No changes in device‐recorded AT/AF frequency or burden were observed with algorithms OFF versus ON or between patients randomized to septal versus nonseptal lead location. Analysis of other secondary outcomes revealed that AT/AF prevention pacing resulted in decreased atrial premature contractions in both the septal (1.9 [0.2–8.7] vs 3.3 [0.3–10.6]× 10 3 /day; P < 0.01) and nonseptal groups (0.9 [0.2–3.3] vs 1.3 [0.3–5.5]× 10 3 /day; P < 0.001). Patients with septal leads had fewer symptomatic AT/AF episodes ON versus OFF (1.4 ± 3.0 vs 2.5 ± 5.2/month, P = 0.01). Conclusion: The combination of three atrial prevention pacing algorithms did not decrease device classified atrial tachyarrhythmia frequency or burden during a 3‐month cross‐over period in bradycardic patients and septal or nonseptal atrial pacing leads. Prevention pacing was associated with decreased frequency of premature atrial contractions and with decreased symptomatic atrial tachyarrhythmia frequency in patients with atrial septal leads. (J Cardiovasc Electrophysiol, Vol. 14, pp. 1189‐1195, November 2003)
No takes yet. Share an insight, caveat, or question.
Padeletti et al. (2003) conducted an RCT in Bradycardia and paroxysmal atrial tachyarrhythmia (n=298). Atrial prevention pacing algorithms vs. Algorithms OFF was evaluated on Device-recorded AT/AF frequency or burden. Atrial prevention pacing did not decrease device-recorded AT/AF frequency compared to OFF, but reduced symptomatic AT/AF episodes in patients with septal leads.
Synapse has enriched 10 related papers. Consider them for comparative context: